Swiss Federal Institute of Technology (ETH) Zurich spin-out Qvanteq raises CHF 4m ($4.3m).

Qvanteq, an ETH Zurich med-tech spin-out founded in 2009, has raised a CHF4m ($4.3m) in its series B round from private investors. Qvanteq plans to use the funds to obtains clinical proof of concept in a “First-in-Man” study. It also plans to acquire CE market approval for a coronary product. The firm said in a statement that it expected a straightforward approval process as surface technology developed by the firm overcomes problems associated with coating technologies.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?